Norges Bank’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-524,213
Closed -$52.8M 2383
2014
Q4
$52.8M Buy
524,213
+100,658
+24% +$7.83M 0.03% 620
2014
Q3
$28.1M Sell
423,555
-423,555
-50% -$27.8M 0.02% 922
2014
Q2
$59.1M Buy
847,110
+437,016
+107% +$29.7M 0.02% 899
2014
Q1
$30M Buy
410,094
+25,771
+7% +$1.92M 0.02% 862
2013
Q4
$26.5M Buy
384,323
+30,587
+9% +$1.98M 0.02% 928
2013
Q3
$22.5M Buy
353,736
+94,722
+37% +$5.73M 0.01% 1010
2013
Q2
$12.5M Buy
+259,014
New +$12.7M 0.01% 1337

Norges Bank's CBST Position: Q1 2015 in Review

Norges Bank sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 524,213 shares — an estimated $52.8M sold.

Norges Bank first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $59.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Norges Bank reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Norges Bank sold 524,213 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $52.8M.
  • Norges Bank first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Norges Bank's CUBIST PHARMACEUTICALS INC position peaked at $59.1M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Norges Bank's 13F filing for Q1 2015, filed 11 May 2015.